Federal appeals court to consider Louisiana’s arguments for banning telehealth abortion

On Wednesday, the U.S. 5th Circuit Court of Appeals will consider Louisiana’s arguments for tightening federal policy around a common abortion and miscarriage drug. The primary target of Louisiana v. Food and Drug Administration and similar lawsuits against mifepristone is to end a Biden-era policy allowing abortion pills to be prescribed without an in-person visit with a provider.

Read More